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Neurite growthNP25), a member of the calponin (CaP) protein family, has previously been
identiﬁed as neuron-speciﬁc protein in the adult rat brain. Here, we show an early onset of NP25 expression
in the chick embryo neural tube. NP25 represents, together with NeuroM, one of the earliest markers for
postmitotic neurons. To elucidate its function in the developing nervous system, NP25 was overexpressed in
E5 and E9 sensory neurons, E7 sympathetic neurons and PC12 cells that show different endogenous NP25
expression levels. Whereas E5 and E9 sensory neurons and PC12 cells, which express low endogenous levels
of NP25, responded by enhanced neurite outgrowth, a reduction of neurite length was observed in
sympathetic neurons, which already express high endogenous levels of NP25. Knockdown of NP25 in sensory
neurons using NP25 siRNA resulted in shorter neurites, whereas reduction of NP25 expression in
sympathetic neurons led to increased neurite length. These results suggest a dynamic function for NP25
in the regulation of neurite growth, with an optimal level of NP25 required for maximal growth.
© 2008 Elsevier Inc. All rights reserved.Introduction
The generation of neuronal circuits in the developing nervous
system involves the speciﬁcation and differentiation of functionally
different neuronal subtypes that engage subsequently to form speciﬁc
contacts and synapses. Important parts of this process include the
migration of neuronal precursors and differentiated neurons to their
ﬁnal location and the production of axons and dendrites. Cell
migration and neurite extension are governed by attractive and
repellant cues in the environment that signal through cell surface
receptors to control cytoskeleton dynamics and themotility of cellular
processes. Our knowledge of the cellular mechanisms and molecular
players involved in cell motility and growth cone movements has
considerably increased in recent years. Interestingly, Rho/Rac/Cdc42
signaling has been found to be essential for both attractive and
repellant movements (Luo, 2000). The calponin family of proteins,
consisting of calponin, SM22α/β, NP25, ARHGEF6, Vav and IQGAP hasohrer).
the Academy of Athens, 11527,
urg Eppendorf, Martinistr. 52,
l rights reserved.been implicated both in direct interactions with the actin cytoskeleton
and regulatory functions through Rho-signaling in various cell types
(Gimona et al., 2002). NP25 is of particular interest due to its selective
expression in the nervous system (Ren et al., 1994), but its role in
nervous system development and neuronal function is not known.
The calponin family of proteins is characterized by the presence of
a 100 amino acid calponin (CaP) homology (CH) domain (Carugo et al.,
1997). The CH domain is present in a large number of actin binding
proteins, including for instance α-actinin, ﬁlamin, dystrophin and
utrophin (reviewed in Gimona et al., 2002). The actin-binding domain
of all these proteins is composed of a tandem array of type1 and type2
CH domains. The calponin family of proteins itself forms, in contrast, a
separate group as only one CH domain is present in these proteins in
the N-terminal region. Their type3 CH domain differs structurally
from type1 and type2 CH domains and is not involved in actin binding
(Gimona et al., 2002). The function of the CH domain in these proteins
is unclear, but for calponin there is evidence for a direct interaction of
the CH domain with the MAP kinases ERK1 and ERK2 (Leinweber,
1999) and for Vav it was shown that the CH domain is important for
the RhoGEF function of this protein (Jögi et al., 2002; Walsh and
Doherty, 1997).
Closely related to calponin are the smooth muscle speciﬁc protein
22 (SM22α and SM22β) (also known as transgelin1 and 2), the Dro-
sophilamuscle protein 20 (MP20) and the neuronal protein 25 (NP25)
(Ren et al., 1994) (also known as transgelin3 (tgln3) and as NP22 (Fan
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NP25 are to about 90% identical, both show only about 75% homology
to calponin. This is due, at least in part, to the presence of three
calponin-like (CLIK) domains in calponin, whereas both NP25 and
SM22α contain only one CLIK domain in the C-terminal region
(Gimona et al., 2002). Interactions with F-actin have been demon-
strated for calponin (through the CLIK domains; (Gimona and Mital,
1998)), whereas the situation for SM22α and NP25 is controversial
(Morgan and Gangopadhyay, 2001; Mori et al., 2004a; De las Heras et
al., 2007).
The physiological function of calponin seems to be the control of
smooth muscle contraction as shown by gain- and loss-of-function
approaches. The smooth muscle vasculature of mice deﬁcient for
calponin-h1 generates less force in response to depolarisation and
show reduced actin expression (Takahashi et al., 2000; Fujihige et al.,
2002). The effect of calponin on the cytoskeleton is thought to be
regulated by its phosphorylation via PKC, as phoshorylated calponin is
no more able to control actin–myosin contraction (Tang et al., 1996).
Also the in vitro interaction of SM22α and NP25 with F-actin was
shown to be dependent on its phosphorylation, which may explain
discrepant ﬁndings on actin binding in co-sedimentation assays and in
stress ﬁber binding (Morgan and Gangopadhyay, 2001; Mori et al.,
2004a;De lasHeras et al., 2007). The analysis of SM22α-deﬁcientmouse
mutants initially revealed changes in actin ﬁlament distribution (Zhang
et al., 2001) but no apparent effect on smoothmuscle development. The
re-analysis of the SM22α-deﬁcient mouse mutant demonstrated,
however, a decreased contractility and actin content of vascular smooth
muscle (Zeidan et al., 2004), recapitulatingmajor effects observed in the
calponin-h1 knockout (Takahashi et al., 2000; Fujihige et al., 2002).
Chronically altered contractility seems to be compensated by increased
response to adrenergic stimulation, providing an explanation for the
unaltered basal homeostatic functions of smooth muscle cells.
NP25 was discovered as neuron-speciﬁc protein, expressed in the
adult rat central and peripheral nervous system (Ren et al., 1994). The
human homolog of NP25 is elevated in the superior frontal cortex of
alcoholics (Fan et al., 2001), and alcohol-dependent changes in NP25
expression and cytoskeletal association have been described in rat
brain (Depaz et al., 2005). Binding of NP25 to ﬁlamentous actin was
observed in co-sedimentation assays and by immunohistological
analysis of ectopically expressed NP25 in cultured human neuroblas-
toma cells (Mori et al., 2004a) and Chinese hamster ovary (CHO) cells
(De las Heras et al., 2007). NP25 overexpression in CHO cells elicits the
generation of short cellular processes (De las Heras et al., 2007).
Here, we focus on the expression and function of NP25 in the chick
nervous system, and demonstrate that NP25 is expressed in all neuronal
lineages analyzed immediately after neuronal precursor cells withdraw
from the cell cycle. NP25overexpression increasedneurite length in cells
with low endogenous NP25 level, i.e. sensory DRG neurons and PC12
cells, but decreased neurite length in sympathetic neurons with high
endogenous NP25 levels. Correspondingly, knockdown of NP25 by
siRNA technology decreased neurite length in immature sensory
neurons and increased neurite length in sympathetic neurons. As co-
localization with F-actin was evident in ﬁlopodia of PC12 cells upon
NP25 overexpression, the function of NP25 in neurite outgrowth may
involve, at least in part, a direct interaction with the actin cytoskeleton.
Materials and methods
Embryo ﬁxation and slice preparation
Embryos were sacriﬁced at different timepoints between E2 and E7
and staged according to Hamburger and Hamilton stages of chicken
development (Hamburger and Hamilton,1951). The embryos were ﬁxed
overnight in 4% paraformaldehyde in 0.1M sodium phosphate buffer
pH7.3 at 4 °C. The embryos were cryoprotected by dehydration in 15%
sucrose for 12h to 48h, depending on the age of the embryos, embeddedinTissue-Tek (Sakura) and immediately frozenondry ice. Frozen sections
(10μmto 14μmthickness dependingon age)were cut on a Leica cryostat.
In situ hybridization on cryosections
Non-radioactive in situ hybridization on cryosections and prepara-
tion of digoxigenin-labelled riboprobes for Scg10 and NP25 were
performed according to established protocols (Ernsberger et al., 1997).
The probe for ggNP25 contained the coding region and the 3′-UTRof the
gallus gallus NP25 cDNA sequence (NCBI accession number XM416634).
The NeuroM probe covers a 726bp long partial region of the coding
sequence (NCBI accession number Y09597 from 245bp to 971bp).
BrdU labelling and detection
For BrdU labelling and detection the Kit II from Roche Diagnostics
was used. Eggs were incubated horizontally for 4days and opened by
cutting a hole in the shell above the embryo. 100μl of warm BrdU
solution (100mM) was applied onto the vitellin arteries. After 1h of
additional incubation time the embryos were ﬁxed, dehydrated,
embedded and cryosected as described above. After in situ hybridiza-
tion using the digoxigenin-labelled riboprobe for ggNP25 (visualized
by NBT/BCIP staining), BrdU detection was performed as described in
the Kit with DAB as substrate.
Primary culture preparation and electroporation
Sympathetic neuronswere prepared by dissociation of paravertebral
lumbosacral sympathetic chain ganglia, dissected at E7/E8. For electro-
poration, 200,000 cells were mixed with either 3μg plasmid solution
(1μg pCAGGS-eGFP + 2μg empty vector or 1μg pCAGGS-eGFP +2μg
pCAGGS-NP25) or 3μg siRNA/Plasmid solution (2μg control siRNA or
2μg siRNA against NP25 together with 3μg pCAGGS-eGFP or with 3μg
pCAGGS-rNP25) and electroporated with the Amaxa Nucleo-
fector according to the Amaxa nucleofection protocol for primary
chicken neurons. 5000 cells per electroporationwere plated on a 35mm
4-well dish precoated with poly-DL-ornithin (Sigma) and laminin
(Invitrogen). The cultures were incubated for 2 days in MEM media
containing 5% FCS,10% HS,1% glutamine and 1% P/S at 37 °C and 5% CO2.
E5 and E9 dorsal root ganglia neurons were prepared as described
previously (Rohrer et al., 1985). For electroporation, 500,000 cells were
mixedwith 9μg plasmid solution (3μg pCAGGS-eGFP+ 6μg empty vector
or 3μg pCAGGS-eGFP + 6μg pCAGGS-NP25) or 9μg siRNA/Plasmid
solution (6μg control siRNA or 6μg siRNA against NP25 together with
3μg pCAGGS-eGFP orwith 3μg pCAGGS-rNP25) and electroporatedwith
the Amaxa Nucleofector according to the Amaxa nucleofection protocol
for primary chicken neurons. 200,000 cells per electroporation were
plated on a 35mm 4-well dish precoated with collagen. The cultures
were incubated for 2days in DMEM media containing 15% CEE, 15% HS
and 1% P/S at 37 °C and 5% CO2. BMP4 (human, R&D Systems, BEM14)
was added to a ﬁnal concentration of 20ng/ml.
The NP25-CAGGS vector contains the coding region of ggNP25
(NCBI accession number XM 416634) and the pCAGGS-rNP25 the
coding region of rrNP25 (NCBI accession numberM84725). The siRNAs
against ggNP25 target the following sequence: 5′-GCAGTGCAGA-
CAACCTTAA-3′ (siNP25-01) and 5′-GCACCTCTGTCTGTAGAGA-3′
(siNP25-02): The control siRNA against GFP (siGFP, Qiagen) targets
the sequence 5′-GCAAGCTGACCCTGAGTTC-3′.
For colocalization studies, 5000 cells from E7 sympathetic ganglia
were seeded on 14mm glass coverslips in 24 well plates precoated
with poly-DL-ornithin (Sigma) and laminin (Invitrogen). E5 DRG cells
were transfected by electroporation as described above with 10μg
pCAGGS-ggNP25myc expression vector. The vector contained the
coding region of ggNP25 tagged with the myc-epitope at the 5′-end.
After electroporation 20,000 cells were seeded on 14mm glass
coverslips in a 24 well plate precoated with collagen (AngioTec
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additional 2days. For inhibition of PKC bisindolylmaleimide II
(Sigma) was added where indicated 6h before ﬁxation to a ﬁnal
concentration of 1μM.
Ballistic transfection
Ballistic transfection of dissociated sympathetic neurons was carried
out using a hand-held gene-gun (Helios Gene-gun, BioRad Hercules, Ca,
USA). Gold particle cartridges were prepared using the manufacturer's
protocol. For transfection with DNA plasmids 1μg of pCAGGS-GFP
together with 10μg pCAGGS-NP25 or control plasmid were used as
described previously (Gutierrez et al., 2004). The DNAwas precipitated
on gold particleswith 20μl of 25mMMgCl2, 8μl 3MCH3COONa and 185μl
100% ethanol at − 30°C for 4–6h. After centrifugation at 16,000×g for
30min, gold particles were washed three times with 100% ethanol,
resuspended in 650μl of 100% ethanol and loaded intoTeﬂon tubing. For
transfection, 1000 and 3000 neurons were plated in a 100μl droplet of
cultured medium in the centre of a 35mm diameter tissue culture dish.
Neurons were incubated for 3–4h to allow the cells to attach, and the
mediumwas removed from the dish just before transfection. The coated
gold particles were shot into the cultured neurons with the gun
pressurized at 140psi. A 70μm nylon mesh screen was placed between
the gun and culture to protect the cells from the shock wave. After
transfection, 2ml of cultured mediumwas added to the culture dishes.
Preparation and transfection of stable cell lines expressing NP25
(NP25-DF1)
Chicken ﬁbroblasts of the DF1 cell line were transfected with pBK-
CMV-ggNP25 (containing the coding region) in 10cm dishes according
to the Qiagen Superfect protocol (exception: 5ng DNA) and incubated
in DMEM+5% FCS and 1% P/S at 37 °C and 10% CO2. From day 1 after
transfection onwards 10μg/ml geneticin were applied to the culture
media. After 1week, residual clonal cell colonies were separated by
transferring into single wells of a 24well plate. After further culturing,
expression levels of NP25 were assessed using RT-PCR and the
western blotting technique. A clonal cell line expressing medium
levels of NP25 was selected.
Transfection of PC12 cells
For overexpression 50,000 cells were plated on a 4 well dish
(35mm) and transfected with 3μg DNA (3μg pCMS or 3μg pCMS-
rNP25) using the Effectene reagent and protocol (Qiagen) and
incubated for additional 2 days in DMEM media containing 5% FCS,
10% HS and 1% P/S at 37 °C and 5% CO2. GFP+-cells were counted as
transfected cells. The pCMS-rNP25 expression vector contained the
coding region of rat NP25 (NCBI accession number M84725).
For colocalization studies 10,000 cells were seeded on glass
coverslips (∅ 14mm) in a 24 well plate and transfected with 0.25μg
pCAGGS-rNP25myc using the Effectene protocol and reagent (Qiagen).
The vector contained the coding region of rattus norvegicus NP25
fused to the myc-epitope at the 5′-end. Cells were incubated without
NGF for 48h and for 5d with NGF (50ng/ml) to allow differentiation.
Bisindolylmaleimide II (Sigma) was added where indicated for
inhibition of PKC to a ﬁnal concentration of 1μM 6h before ﬁxation.
Semiquantitative RT-PCR
cDNA synthesis on total RNA from NP25-DF1 cells or sympathetic
ganglia cells (RNeasy Mini Kit, Qiagen) was performed using the M-
MLV Reverse Transcriptase Kit (Invitrogen). For the detection of Np25
and Gapdh mRNA levels following primer combinations and the Taq
Polymerase Kit (Invitrogen) for PCR reaction were used: ggNP25-for
5′-GCTAACAGAGGACCAAGCTAT-3′, ggNP25-rev 5′-GCCTTGGCATCCCG-TAGCCC-3′, ggGAPDH-S388 5′-AAGGGTGGTGCTAAGCGT-3′, ggGAPDH-
A1118 5′-GCAGGGGCTCCAACAAAG-3′.
All PCR reactions were performed within the linear range that has
been determined empirically for each pair of primer and cell
preparation. The PCR products were separated on a 1% agarose gel
and visualized with ethidium bromide. Quantiﬁcation was done with
the ScionImage Software version 1.63 (Scion Corporation) and the
Np25 mRNA level was normalized to Gapdh mRNA level.
NP25 antibody
Gallus gallus NP25 was 6xHis-tagged at the N-terminus and
expressed in E. coli of the XL1-Blue strain in the presence of IPTG using
the pQE-vector (Qiagen). The protein was puriﬁed using immobilized
metal afﬁnity (iMAC) columns and antibodies were raised against the
full length 25kD protein in rabbits (Rockland, Inc.). The antibodies
were immunopuriﬁed from the blood serum and tested for speciﬁcity.
Protein blotting
For protein preparation 20 chains of E7 paravertebral sympathetic
ganglia and DRGs of 10 E5 and 10 E9 chicken embryos respectivly were
dissected and dissociated as described above. NP25-DF1 and PC12 cells
were also dissociated and the dissociated cells were pelleted with short
centrifugation (100×g, 10min). Pelleted cells were lysed with cold lysis
buffer (50mM Tris/HCl pH7.4, 150mM NaCl, 40mM NaF, 5mM EDTA,
5mM EGTA, 1mM Na3VO4, 1% Triton X-100, 0.1% Na-deoxycholat, 0.1%
SDS, 1mM PMSF, 10μg/ml aprotinin) for 10min on ice. After short
centrifugation (10,000×g,10min, 4 °C) the supernatantwas collected and
protein content determined with the DC protein assay (BioRad). After
conventional SDS-PAGE and semi-dry blotting to PVDF membrane
(BioRad), the membrane was blocked with 5% instant milk powder in
TBST (10mM Tris/HCl pH8, 150mM NaCl, 0.05% Tween20) for 1h before
antibody incubation. The anti-NP25, the anti-Actin (Dianova, MS-1295)
and the anti-βIII Tubulin antibody (TUJ1 antigen, HISS Diagnostics,
MMS-435P) were diluted 1/2500 in blocking solution and incubated o/n
at 4 °C. After washing 3 times with TBST the appropriate HRP coupled
secondary antibody (1/5000 in TBST) was incubated for 1h at RT and
washed of twice (TBS). The blots were developed using standard ECL
according to manufacturer's instructions (Pierce, SuperSignal). For
quantiﬁcation of protein bands the software ScionImage version 4.03
from (Scion Corporation) was used with the macro “gel blot 2”.
Immunostaining
Cryosections
Frozen slices were rehydrated for 10min in PBS and incubated for
1h in staining buffer (PBS + 5% FCS and 0.2% Triton X-100). Primary
antibody for NP25 and βIII-Tubulin (TUJ1 antigen, HISS Diagnostics,
MMS-435P) were diluted 1/500 in staining buffer and incubated for 2h
at RT. Slices were washed twice with PBST (PBS + 0.2% Triton X-100).
Fluorophore coupled secondary antibody in PBST + 0.1% DAPI was
incubated for 30min at RT and washed of twice with PBS. Slices were
covered with AquaPolyMount covering media (Polysciences, Inc.) and
glass cover slips.
Cell culture
Cell culture dishes were washed once with PBS and cells were ﬁxed
using 4% paraformaldehyde in 0.1M sodiumphosphate buffer for 15min.
Cells were washed with PBS once and stainings were performed as for
cryosectionsdescribedabove. For visualization ofNP25myc theanti-myc
antibody (Serotec, MCA 1929) was diluted 1/1000 in staining buffer. For
double staining of NP25 and F-actin the speciﬁc Alexa488-coupled
phalloidin toxin (MoBiTec) was diluted 1/200 and applied during
secondary antibody incubation. Stainings were mounted with Aqua-
PolyMount (Polysciences) and covered with glass cover slips.
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Transfected cells (GFP+)were analysedusing theMetamorph Imaging
System (version 4.6, Universal Imaging Corporation). Length of neurites
were measured as straight lines from the middle of the cell body to the
end of the neurite visualized by TUJ1 staining in primary cultures or by
GFP ﬂuorescence in PC12 cells. Fast Sholl analysis (Gutierrez and Davies,
2007) with deduction of total length was carried out to analyze neurite
outgrowth in sympathetic neurons overexpressing NP25. All results are
given as mean ± s.e.m. of at least three independent experiments with a
minimum of 229 single neurons per condition analyzed. For statistical
analysis paired Student's t-test was used, except for the rescue
experiment, where ANOVA analysis was performed.
Results
Expression of Np25 mRNA
To study expression and function of NP25 during development the
chick embryo was chosen. Cloning of the chick homologue revealed
that the protein and nucleic acid sequence of chick NP25 is to 97% andFig. 1. Onset of Np25mRNA expression in the developing chick spinal cord (NT), dorsal root g
the expression of NeuroM, an early marker of neuron development and Scg10, a marker of ea
C, F, Ii, Ll, Scg10 expression. At st11 and at st14 Np25 and NeuroM are expressed in the spina
expressed, Np25 expression again starts prior to Scg10 (g, h, i). Please note that the highest lev
subventricular zone rather than in the mantle zone (J, K). Np25 mRNA is not detectable in t81% identical to themouse sequence, respectively (Supplementary Fig.
1). The onset of Np25 expression was analysed in comparison to the
expression of NeuroM and Scg10, frequently used as early neuronal
marker genes (Roztocil et al., 1997; Wuenschell et al., 1990). In situ
hybridisation on sections of stage 11, stage 14, stage 18 and stage 24
(E2–E4) chick embryos demonstrated that Np25 expression, like
NeuroM and Scg10, is restricted to the central and peripheral nervous
system (Fig. 1). The expression pattern of Np25 in the spinal cord (Figs.
1E, H, K) and the absence in peripheral nerves (Fig. 1K, asterisks)
strongly suggests that Np25 expression is restricted to the neuronal
lineage. Np25 expression is initiated together with NeuroM at stage 11
in the spinal cord (Figs. 1A, B) and stage 17 in the DRGs (not shown). In
the paravertebral sympathetic ganglia Np25 expression was ﬁrst
observed at stage 18 (Fig. 1h). In stage 24 spinal cord, Np25 is strongly
expressed in a bilateral stripe of cells located between the proliferative
ventricular zone and the subpial zone, with decreased expression in
the mantle region (Fig. 1K). This region was ﬁrst identiﬁed during the
analysis of NeuroM expression and was characterized as a zone where
undifferentiated precursor cells leave the ventricular zone and
possibly pause en route to their ﬁnal location in the mantle zone
(Fig. 1J) (Roztocil et al., 1997). The direct comparison between Np25anglia (DRG) and sympathetic ganglia (SG). Np25 expression was analysed in parallel to
rly differentiated neurons. A, D, Gg, Jj, NeuroM expression, B, E, Hh, Kk, Np25 expression,
l cord, whereas no Scg10 expression was detected (A–F). In the SG where NeuroM is not
els of Np25 and NeuroM expression in the spinal cord were reached at the intermediate,
he peripheral nerve (K, asterisks). Scale bar=100 μm.
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sion pattern, not only in the spinal cord but also in the sensory
neurons of the DRG. Compared to Np25 and NeuroM, Scg10 expression
starts with a considerable delay, with an initial onset at brachial spinal
cord levels between stage 15 and 18 (Figs. 1F, I). A further difference is
Scg10 expression in the spinal cord ﬂoor plate, not observed for Np25
and NeuroM (Figs. 1G–L, black arrowheads). Also in the peripheral
nervous system Scg10 is expressed later than Np25 and NeuroM.
Expression of NP25 protein
NP25 protein expression was analysed using a rabbit polyclonal
antibody raised against the full-length protein. The antibody recog-
nizes a single protein of about 23kD onwestern blots loadedwith DRG
or SG lysates (Supplementary Fig. 2A, lanes 1–3). Cross sections of E5
(stage 27, Figs. 2A–C) and E7 (stage 31, Figs. 2D–F) chicken embryosFig. 2. NP25 protein expression in the developing chick spinal cord, dorsal root ganglia
(DRG) and sympathetic ganglia (SG). A–F, Parallel cross sections from E5 (st27) and E7
(st31) chick embryos were processed for co-immunostaining with NP25 (A, D) and βIII-
Tubulin (B, E, TUJ1 antigen) antibodies (C, F, overlay of A+B and D+E, respectively).
NP25 was detected in the spinal cord, DRG and SG neurons. Strong NP25-IR was
observed in the dorsal root entry zone and commissural ﬁbers (A, D, white arrowheads).
NP25 is absent from the TUJ1-positive motorneuron tracts of the ventral root (A, B and
D, E, yellow arrowheads). At st31 NP25 protein expression is stronger in the dorsal half
of the spinal cord than in the ventral half. G–L, E5 sensory DRG and E7 SG neurons were
isolated, dissociated and cultured for two days and then processed for co-immunos-
taining with NP25 (G, J) and βIII-Tubulin (H, K, TUJ1 antigen) antibodies (I, L, overlay of
G+H and J+K, respectively). E5 sensory neurons showed much lower NP25-IR (G) as
compared to E7 sympathetic neurons (J). Scale bar=100 μm.
Fig. 3. Np25 is not expressed in proliferating progenitors in the spinal cord. (A, B) E4
(st23) chick embryos were BrDU labeled in ovo (1 h pulse), ﬁxed, sectioned and
sequentially stained for BrdU (brown) and Np25 mRNA (blue). The vast majority of
BrdU-labeled nuclei were observed in the subventricular zone (arroeheads) where S-
phase neuroepithelial cells are located (A) and where also some Np25 expressing cells
are detected (B). (C, D) Analysis of a close up, revealing that all Np25-positive cells are
negative for BrdU-labeling (e.g. black arrowhead in C, D). Scale bar=100 μm.were stained for βIII-Tubulin (TUJ1-antigen, Figs. 2B, E) and for NP25
(Figs. 2A, D) to visualize neurons as well as axonal tracts. In contrast to
the strong NP25 mRNA signal in the bilateral stripe lateral to the
ventricular zone and the weaker signal in the mantle layer (Fig. 1K),
the NP25-immunoreactivity (NP25-IR) at stage 27 is found to be
uniformly distributed in the neurons of the spinal cord with no signal
in the ventricular zone (Fig. 2A). At this stage the strongest NP25-IR is
observed in the corticospinal tracts at the lateral wall of the spinal
cord, the dorsal roots and the commissural ﬁbers crossing the ﬂoor
plate (Fig. 2A, white arrowheads). This led to a clear co-localization of
NP25 and TUJ1 staining in these areas (Fig. 2C). The strong Np25
mRNA expression during the transit from ventricular zone to mantle
zone thus does not lead to a massive increase in NP25 protein. Also at
stage 31, dorsal roots (not shown), dorsal root entry zones (Fig. 2D,
white arrowhead) and the dorsal half of the spinal cord are
prominently stained, whereas the ventral half shows only very weak
staining. At stage 27 and stage 31 the TUJ1-positive motoneuron ﬁbers
of the ventral roots are NP25-negative (Figs. 2A, B, D, E, yellow
arrowheads). The peripheral DRGs and SGs in contrast show a uniform
expressionwith a strong localization of NP25 protein in their axons. As
expected from the in vivo stainings, cultured E5 sensory neurons show
a much lower NP25 content, compared to the NP25 expression levels
in E7 sympathetic neurons (Figs. 2G–L).
The antibody staining is speciﬁc for NP25 as revealed by the lack of
NP25-IR in thepresenceof anexcessof full-lengthNP25 (Supplementary
Fig. 2B). The cellular staining pattern both in vitro and in vivo indicates
that neuronal processes, axons inparticular, showstrongNP25-IR andan
even distribution in the cell bodies of NP25 expressing neurons.
Np25 expression and cell cycle exit
The early onset of Np25 expression raised the question whether
proliferating neural precursor cells would already express Np25.
Using short-term BrdU labeling to identify proliferating S-phase cells
in the spinal cord, in combination with in situ hybridisation to detect
Np25 RNA expression, we observed that the vast majority of Np25-
439M. Pape et al. / Developmental Biology 321 (2008) 434–443positive cells are located lateral to the BrdU-labeled ventricular zone
(Figs. 3A, B). Also in the regionwhere BrdU-labeled S-Phase nuclei and
Np25-expressing cells were both present, co-expression of Np25 and
BrdU was never observed (see high-power magniﬁcation Figs. 3C, D).
Together with the previous observation that NeuroM expressing cells
represent early postmitotic cells in the chick spinal cord (Roztocil et
al., 1997), the present data suggest that expression of Np25 and
NeuroM is closely linked. The expression starts in postmitotic cells that
have just left the ventricular zone but have not yet started their
migration to outer layers.
Effect of NP25 overexpression on neurite outgrowth from sensory and
sympathetic neurons and PC12 cells
The structural similarity between NP25 and related calponin
family members, together with the onset of expression in migratory
cells in the spinal cord and the strong expression in axonal tracts,
suggested direct or indirect interactions of NP25 with the cytoskele-
ton. A likely consequence of this interaction would be effects on cell-
and process motility. To investigate this potential function, NP25 was
ectopically expressed in sensory and sympathetic neurons and PC12
cells and effects on neurite outgrowth were analysed. All these cellFig. 4. NP25 overexpression in cells from E5 (A) and E9 (B) dorsal root ganglia (DRG), PC12
neurons led to an increase in length of the longest neurite. (B) Overexpression of NP25 in E9 D
cells was achieved by electroporation. In both cases, data shown represent the analysis of ap
cells were transfected with NP25 expression vector by lipofection and showed increased
condition from three independent experiments. (D, E) Overexpression of NP25 in E8 SG neur
of attached cells (E). Both transfection protocols resulted in decreased total neurite length d
neurons (gene gun transfection) per condition were analyzed in three independent experimtypes express NP25 endogenously, but they show differences in the
NP25 expression level (Supplementary Fig. 2A, representative Wes-
tern blots). When compared to the NP25 expression level in E5 DRGs
neurons (Supplementary Fig. 2A lane1 and lane 4), E9 DRG neurons
(Supplementary Fig. 2A lane2) show a slightly reduced expression
level (87.9% ± 5.2%, n = 3), whereas neurons from E7 SG (Supplemen-
tary Fig. 2A lane3) show a much higher (350.8% ± 160.0%, n = 4) and
PC12 (Supplementary Fig. 2A lane5) a considerably lower expression
level (14.5% ± 0.1%, n = 2). The relative amounts were analyzed by
quantiﬁcation of anti-NP25 western blot bands and normalized to the
actin content (anti-Actin antibody). Normalization to the βIII-Tubulin
content (anti-TUJ1 antibody) resulted in similar relative NP25 protein
levels (not shown).
NP25 was ﬁrst overexpressed in cultured immature sensory
neurons from E5 DRGs. The cells were either co-transfected with
expression vectors for NP25 and eGFP or with eGFP and empty
CAGGS-vektor and ﬁxed after two days in culture. The length of
neurites was signiﬁcantly increased in transfected GFP-positive
neurons with elevated NP25 expression levels as compared to control
transfected neurons (Fig. 4A, from 105.2μm±18.0μm in control to
129.5μm±22.2μm in NP25 transfected cells, p b 0.05). The over-
expression of NP25 had no effect on cell survival (overexpression:cells (C) and E8 sympathetic ganglia (SG) (D, E). (A) Overexpression of NP25 in E5 DRG
RG neurons also resulted in an increased neutite length. Overexpression of NP25 in DRG
proximately 300 neurons per condition from three independent experiments. (C) PC12
neurite length. Data shown represent the analysis of approximately 500 neurons per
ons was achieved by electroporating cells before plating (D) or by gene gun transfection
educed from Fast Sholl analysis. Approximately 350 neurons (electroporation) and 230
ents each. ⁎=pb0.05; ⁎⁎=pb0.01.
Fig. 5. Np25 knockdown using siRNAs. (A) Using an NP25-expressing avian cell line
(NP25-DF1), two siRNA oligonucleotides (siNP25-01; siNP25-02) were selected that
decreased NP25 mRNA (detected by RT-PCR) and protein expression levels (detected by
western blot) after 2d in culture, compared to the effects of an unrelated control siRNA
directed against GFP (siGFP, control). (B) Quantiﬁcation of the decrease of Np25 mRNA
level in siNP25-01/-02 transfected cells compared to control transfection. The effects on
Np25 mRNA expression were normalized to the expression of Gapdh. ⁎⁎=pb0.01.
440 M. Pape et al. / Developmental Biology 321 (2008) 434–44396.9% ± 4.1% cells, in % of transfected cells in control, p = 0.423). To test
wether the overexpression of NP25 leads to the same effects in more
mature neurons, NP25 was overexpressed in cultured E9 DRG
neurons, which also show low endogenous NP25 expression (Supple-
mentary Fig. 2A). As in E5 sensory neurons, NP25 overexpression
resulted in an increase in neurite length of 27% ± 12% compared to
transfected neurons in the control cultures (Fig. 4B, from 293.8μm±
45.2μm in control to 369.7μm±32.2μm in NP25 transfected cells, p b
0.05). The transfection had again no effect on cell survival (over-
expression: 94.2% ± 8.1% cells, in % of transfected cells in control,
p = 0.444). To further conﬁrm these results in another cell type with
low endogenous NP25 expression levels, the well-established PC12
phaeochromocytoma cell line was used (Greene and Tischler, 1976).
PC12 cells showamuch lower expression level of NP25 compared to E5
and E9 DRG neurons (Supplementary Fig. 2A) and can be induced to
differentiate into neuron-like cells in response to NGF, resulting in a
strong increase in NP25 expression (Mori et al., 2004b). To investigate
the potential role of NP25 in neurite outgrowth, PC12 cells were
transfected by lipofection with either pCMS-NP25 or pCMS alone. We
observed that the neurite length (Fig. 4C) was signiﬁcantly increased
by increasing NP25 expression (161%). The mean length of the longest
neurite increased from 9.85μm±1.02μm in control to 15.66μm±
1.42μm in NP25 transfected cells (p b 0.05) and at the same time the
proportion of cells without neurites signiﬁcantly decreased from53% ±
5% in controls to 39% ± 6% in NP25 transfected cells (p b 0.01, not
shown). Cell survival was not affected by NP25 expression (96.5% ±
2.90% cells in % of transfected cells in control, p = 0.225).
In contrast to the effects in sensory neurons and PC12 cells,
electroporation of E8 sympathetic neurons with NP25-CAGGS expres-
sion vector before plating of the cells caused a signiﬁcant reduction in
neurite length (Fig. 4D, 38%, p b 0.01). Similar results were observed
using an alternative approach that involved using a gene gun to ﬁre
gold microcarriers coated with NP25- and GFP-CAGGS expression
vectors or GFP-CAGGS vector alone into cultured sympathetic neurons.
Neurite length was reduced by 27% (Fig. 4E, p b 0.01). NP25 over-
expression had no effect on cell survival (103.4% ± 3.9% cells in % of
transfected cells in control, p = 0.369). Taken together, these results
indicate that overexpression of NP25 results in stimulation of neurite
outgrowth from cells with low endogenous levels of NP25 (DRG
neurons and PC12 cells) and inhibition of neurite growth fromneurons
with high endogenous levels of NP25 (sympathetic neurons).
Effects on neurite outgrowth of RNAi-mediated Np25 knockdown in
sensory and sympathetic neurons
To conﬁrm the function of NP25 in neurite growth, loss-of-function
experiments were carried out in sympathetic and sensory neuron
cultures. To interfere with the action of NP25, appropriate siRNA
nucleotides were selected, using a newly generated avian cell linewith
constitutive NP25 expression (NP25-DF1). The siRNAs siNP25-01 and
-02 reduced the levels of Np25 mRNA expression to less than 40% of
controls, as revealed by RT-PCR (Figs. 5A, B). The decrease in Np25
mRNAwas paralleled by a strong decrease in NP25 protein expression,
analysed by western blot (Fig. 5A). Control transfections were done
with siRNAs directed against GFP (siGFP), which is not expressed in
this cell line. Knockdown of Np25 with siNP25-02 in E7 sympathetic
neurons also produced a highly signiﬁcant reduction (p b 0.01) in
Np25 mRNA expression to about 60% of controls (Fig. 6A). The high
NP25 expression levels in sympathetic neurons (Supplementary Fig.
2A) may explain the smaller effect on Np25 mRNA level after siRNA
transfection in sympathetic neurons versus the NP25-DF1 cell line.
E7 sympathetic neurons were electroporated with siNP25-02 or
siGFP control siRNA and analysed for effects on neurite growth (Fig.
6B). Np25 knockdown resulted in longer neurites (from 201.1μm±
4.2μm in control to 226.5μm±9.0μm in siNP25-02 transfected cells,
p b 0.01). The increase in neurite length by knockdown of NP25 wasrescued by simultanous overexpression of the rat homolog of NP25
(pCAGGS-rNP25) which is not targeted by the siRNA (Fig. 6B, rescue).
This excludes unspeciﬁc effects by transfection of siNP25-02. We also
saw no effects on the survival of the cells (knockdown: 95.4% ± 4.5%
cells p = 0.423 and rescue: 97.2% ± 1.8% p = 1.000 in % of transfected
cells in control). Together, these ﬁndings support the idea that the
high NP25 expression level in sympathetic neurons displays a
negative effect on neurite outgrowth. Reduction in the expression
level relieves this inhibition and leads to longer neurites.
The inhibition of NP25 function in E5 sensory DRG neurons lead
instead to a decrease in the length of the longest neurite from 199.1μm±
42.5μm in control to 171.6μm±35.4μm in siNP25-02 transfected cells
(p b 0.05, Fig. 6C), conﬁrming the positive effect of NP25 over-
expression in these cells with low endogenous NP25 expression. The
simultaneous transfection of siNP25-02 and pCAGGS-rNP25 rescued
the negative effect on neurite length. Here, the neurite length not only
reached control levels but increased signiﬁcantly compared to the
control (from 199.1μm±42.5μm s.e.m. in control to 229.9μm±50.4μm,
p b 0.05, Fig. 6C). Again, we saw no effects on the survival of cells
(knockdown: 105.0% ± 7.0% cells p = 0.199 and rescue: 101.0% ± 8.4%
p = 0.742 in % of transfected cells in control).
Interaction between NP25 and F-actin in cultured sensory and
sympathetic neurons and in PC12 cells
The effects of NP25 on neurite outgrowth observed in gain- and
loss-of-function experiments raised the question whether the
Fig. 6. Np25 knockdown in sensory and sympathetic neurons. (A) In response to
electroporation with siNP25-02, Np25 mRNA levels in sympathetic neurons were
decreased by about 40% after 2 days in culture. (B) The Np25 knockdown in sympathetic
neurons resulted in a signiﬁcant increase in neurite length (dark grey). This effect was
rescued by simultanous overexpression of the rat homolog of NP25 (rNP25), which is
not targeted by the siRNA (hatched dark grey). Data shown represent the analysis of
approximately 550 neurons per condition from four independent experiments. (C)
Reduction of Np25 expression levels in sensory neurons resulted in a decrease of neurite
length. This effect was again rescued by overexpression of rNP25 (hatched dark grey).
Approximately 300 neurons per condition were analyzed in three independent
experiments. ⁎=pb0.05; ⁎⁎=pb0.01.
Fig. 7. Localisation of NP25 and F-actin in cultured E7 sympathetic (SG) neurons, E5
sensory (DRG) neurons and PC12 cells. Confocal images of sympathetic neurons (A–C),
sensory neurons (D–F) and PC12 cells (G–O) double-stained for NP25 (A, D, G, J, M) and
F-actin (B, E, H, K, N) and merged pictures (C, F, I, L, O). In E7 SG neurons co-localisation
of endogenous NP25 (A, red) and F-actin (B, ﬂuorophore-coupled phalloidin, green) was
not detected (C). In particular, neurites and spines were devoid of signiﬁcant NP25
staining. In PC12 cells and E5 DRG neurons NP25myc was overexpressed and visualized
with an anti-myc antibody (D, G, J, M red) and F-actin with ﬂuorophore-coupled
phalloidin (E, H, K, N, green). In sensory neurons no co-localisation was observed (F). In
unstimulated PC12 cells NP25 and F-actin seem to co-localize in distinct ﬁlopodia-like
structures at the cell periphery (white arrowheads) with high actin content (yellow
areas in I). In transfected PC12 cells treated with NGF for 5d there is partial
colocalization in ﬁlopodia-like structures (white arrowheads) at the cell body (L), but
also in growth cones (yellow areas in O, white arrowhead). Scale bar=25 μm.
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actin cytoskeleton. To address this issue, E7 wt sympathetic neurons
and NP25myc overexpressing E5 sensory neurons were maintained in
cultures for two days and subsequently co-stained for NP25 and F-
actin with anti-NP25 antibody and Alexa-ﬂuorophor-coupled Phalloi-
din to visualize NP25 and F-actin, respectively. The cells were analyzed
by confocal microscopy, revealing a submembraneous F-actin cortex
in the cell bodies, axons (Figs. 7B, E) and growth cones (not shown). In
contrast, NP25-IR was found to be present throughout the cytoplasm
in neuronal cell bodies and neurites (Figs. 7A, D). There was no clear
evidence for a co-localisation of NP25-IR and F-actin in these neurons
(Figs. 7C, F). In particular, there was no enrichment of NP25-IR in
submembraneous F-actin cortex. As actin-binding activity of calponin/
transgelin family members seems to be inhibited by PKC phosphor-
ylation (Fu et al., 2000; De las Heras et al., 2007) PKC was blocked in
cultured sympathetic neurons. However, also in the presence of the
PKC-inhibitor bisindolylmaleimide II, no co-localization of NP25-IR
with F-actin could be demonstrated (not shown).In contrast, co-localization of NP25-IR and F-actin was observed in
PC12 cells transfected with NP25 expression vectors and analyzed two
days after transfectionwithout NGF or ﬁve days after transfectionwith
NGF added to the culture media (Figs. 7G–O). Short cellular processes
that most likely represent ﬁlopodia showed typical F-actin ﬁbers (Figs.
7H, J white arrowheads) that co-stained for NP25 (Figs. 7I, L white
arrowheads). In PC12 cell cultures treated with NGF there was also
partial co-staining evident in growth cones of elongating neurites. The
co-localization of NP25 was not increased or decreased by inhibition
of PKC (not shown).
The effects of NP25 on neurite growth may also result from an
indirect interaction with the cytoskeleton, as two related RhoGAP
proteins were identiﬁed in a yeast two-hybrid screen as potential
NP25 interaction partners (M.G., C.V.D. and H.R.; preliminary
observation). Both RhoGAP genes displayed a neuron-speciﬁc expres-
sion similar to NP25 (not shown).
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The developmental expression pattern and function of NP25/
Transgelin3, a member of the calponin protein family, was analyzed.
Here, we describe that Np25 RNA expression starts very early in the
neuronal lineage, immediately after cell cycle exit of neural progeni-
tors. Overexpression and knockdown experiments in three different
neuron subtypes demonstrate effects on neurite growth that strongly
correlate with the level of endogenous NP25. Depending on the
endogenous NP25 levels, increased or decreased neurite growth was
observed in both gain- and loss-of-function experiments. This suggests
that neurite growth requires an optimal level of NP25 protein.
NP25 expression in the developing nervous system
Nervous system development is characterized by early anteropos-
terior and dorsoventral patterning processes leading to regional
identities. Different neuronal subtypes are subsequently generated,
involving networks of transcription factors that include patterning
factors as well as proneural bHLH proteins like Mash1 and Ngn1-3.
Proneural proteins accumulate at a high level, resulting in the
activation of a neuronal differentiation pathway. As proneural genes
are downregulated before progenitor cells exit the cell cycle and begin
to differentiate, their ability to promote neuronal differentiation relies
on the induction of downstream regulatory genes that execute the
neuron differentiation program (Bertrand et al., 2002). The bHLH
genes of the NeuroD family represent such differentiation genes acting
downstream of proneural genes. Of particular interest is NeuroM,
expressed in the spinal cord transiently in cells that have ceased
proliferating but have not yet begun to migrate into outer layers and
before the onset of NeuroD expression (Roztocil et al., 1997). Also in
the sensory neurons of the peripheral nervous system NeuroM
expression closely follows cell proliferation at the transition between
undifferentiated and differentiated neural precursors. Interestingly,
NP25 and NeuroM show a similar expression pattern in the spinal
cord, including the onset of expression in postmitotic cells. This very
early expression start of a pan-neuronal terminal differentiation gene
raises the possibility that NP25 might represent a direct target gene of
proneural genes. It should be pointed out that although the
transcriptional networks involved in the determination/speciﬁcation
of distinct neuronal phenotypes have been described for many
neuronal lineages in great detail, the link from subtype determination
to the expression of terminal differentiation genes is generally much
less well understood. Thus it is still unclear, whether generic neuronal
differentiation, i.e. the expression of genes that are present in all types
of neurons are controlled by a common set of transcription factors in
all neuronal lineages or by domain- or lineage-speciﬁc subsets
(Edlund and Jessell, 1999). As NP25 seems to be one of the earliest
pan-neuronal genes expressed it may be a useful target gene to
address these issues.
Analysis of NP25 protein expression conﬁrmed the neuron-speciﬁc
localization but it is also evident that the NP25 expression levels in
differentiated neurons are variable, with much lower levels in
motoneurons as compared to the dorsal spinal cord, for instance.
Similar differences in NP25 expression between different neuron
types have been described for the adult rat brain (Ren et al., 1994;
Depaz et al., 2005). Although staining in cultured cells and tissue
sections demonstrates a rather uniform cytoplasmic localization, ﬁber
tracts and the dorsal root entry zone show high expression.
A function of NP25 in neurite outgrowth
The presence of the CH domain and the conserved actin binding
domain from SM22α (Fu et al., 2000) suggested a potential function in
cell structure and/or movement through interaction with the actin
cytoskeleton. The interaction with the cytoskeleton was supported bythe demonstration that NP25 binds to F-actin in co-sedimentation
assays and that upon overexpression in neuroblastoma cells NP25-IR
was observed in F-actin bundles of stress ﬁbres (Mori et al., 2004a).
Ectopic expression of the human NP25 homolog (also known as
hNP22, Fan et al., 2001) in Chinese hamster ovary (CHO) cells resulted
in the induction of short cellular processes (De las Heras et al., 2007).
As the role of NP25 in developing neurons had not been investigated,
and all functions were deduced from overexpression experiments, we
have analysed the function of NP25 in two different primary neuron
culture models, chick sensory DRG and sympathetic neurons and the
PC12 cell line, using LOF and GOF approaches. PC12 cells are a cell line
derived from adrenal pheochromocytoma and represent a classical
model for sympathetic precursors (Greene and Tischler, 1976). In
sensory DRG neurons and PC12 cells, NP25 overexpression increases
the length of neurites, whereas in sympathetic neurons neurite length
is decreased. These opposing effects of NP25 overexpression on
neurite growth in different cell types appear to be related to the
endogenous level of NP25, in that cells with low endogenous NP25
level respond with enhanced neurite growth whereas cells with high
endogenous NP25 level respond with decreased neurite growth. The
alternative possibility, that NP25 displays opposing functions in
sensory and sympathetic lineages cannot be formally excluded.
However, the observation that NP25 enhances neurite extension in
the sympathoadrenal PC12 cells, which show low endogenous NP25
expression, but inhibits neurite outgrowth in sympathetic neurons
with high NP25 expression, strongly supports a level dependent
action of NP25 rather than a lineage speciﬁc function. Additional
evidence for level-dependent functions was obtained from knock-
down and rescue experiments. SiRNA knockdown of NP25 in cells
with low endogenous NP25 level resulted in shorter neurites, whereas
siRNA knockdown of NP25 in cells with high endogenous NP25 level
led to increased neurite length. Both effects could be rescued by
simultanous overexpression of rNP25. Interestingly, in siRNA treated
sensory neurons the overexpression of rNP25 increased neurite length
above controls, revealing a positive correlation between neurite
outgrowth and NP25 expression in cells with low endogenous NP25
levels. In sympathetic neurons, the rescue just compensated the
increased neurite growth elicited by NP25 knockdown, which is in
agreement with the notion that NP25 levels reached under these
conditions are lower than during NP25 overexpression in control cells
and thus do not result in neurite growth inhibition. Taken together,
these results suggest that there is an optimal NP25 level for maximum
neurite growth and that neurite growth is decreased when NP25
levels fall below or rise above this optimum.
Are the effects of NP25 in developing primary neurons and the
PC12 cell line mediated through interactions with F-actin? Confocal
analysis of sympathetic neurons double-stained for NP25 and F-actin
showed no accumulation of NP25-IR to the submembraneous F-actin
cortex. The small areas of co-localisation are most like due to an
overlap of the general cytoplamic localization of NP25-IR and F-actin
cortex. In particular, ﬁlopodial F-actin was not decorated by NP25-IR.
Endogenous NP25 levels in immature DRG neurons are very low and
no evidence for F-actin binding was observed in these cells, even upon
ectopic NP25 overexpression. In contrast, ﬁlopodial/lamellopodial
processes arising from the cell body of NP25-transfected PC12 cells
consistently showed co-localization of NP25-IR and F-actin. This was
evident in cells with and without NGF treatment. Interestingly there
was also partial co-localisation of NP25 and F-actin in growth cones of
elongating neurites from PC12 cells treated with NGF. As the strongest
effects of NP25 overexpression were observed in the PC12 cell line, it
may be argued that NP25 functionally interacts with the actin
cytoskeleton and that this interaction also takes place in the DRG
and sympathetic neurons but may be below the detection limit. The
possibility that F-actin binding of NP25 is inhibited in sympathetic
neurons by phosphorylation, as shown for calponin family members
(Fu et al., 2000; Winder and Walsh, 1990), was excluded, as NP25 did
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inhibitor. It should also be noted that biochemical evidence for F-actin
interaction is controversial for NP25, as well as immunohiostological
results on stress ﬁber binding, which are difﬁcult to interpret in view
of the strong cytoplasmic NP25 expression (De las Heras et al., 2007;
Mori et al., 2004a).
The effects of NP25 on neurite growth and the cytoskeleton may not
necessarily depend on direct interactionwith the cytoskeleton but may
be mediated by modulation of Rho signaling. Neurite growth during
development and regeneration is positively regulated by cdc42 and rac,
whereas RhoA activity is correlatedwith growth arrest and growth cone
collapse (Luo, 2000). RhoGTPases cycle between an active, GTP-bound
and the inactive, GDP-bound state (reviewed in Symons and Settleman,
2000). RhoGTPase-activating proteins (RhoGAPs) stimulate the intrinsic
hydrolytic activities of RhoGTPases to terminate Rho function. In a Two-
Hybrid screen with rat brain lysates and rNP25 as bait two similar but
different RhoGAP proteins were identiﬁed as potential NP25 interaction
partners (M.G., C.V.D. and H.R., preliminary observation). Interestingly,
the identiﬁed clones contain three GAP domains and represent, together
with tGAP1 (Modaressi et al., 2004), so far the only proteins with more
than one GAP domain. Although the functional interaction of NP25 and
these RhoGAP proteins needs to be conﬁrmed and further characterized,
our ﬁndings suggest the possibility that NP25 may regulate the actin
organization both indirectly, through the control of RhoGTPase activity
and by direct F-actin binding.
In conclusion, the present data demonstrate that NP25, expressed
at the very onset of neuron differentiation in all neuronal lineages
analyzed, is involved in the control of neurite growth. It is possible
that other functions that depend on cytoskeletal dynamics like neuron
migration and dendrite growth may also represent NP25 targets.
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